Norfolk Southern’s flawed response released more than twice the toxics released in the initial derailment,…
50% of CIOs say their board expects them to deliver continuous innovation. 80% of CIOs…
NEW YORK–(BUSINESS WIRE)–MFA Financial, Inc. (NYSE: MFA) (the “Company”) announced today that its Board of…
Noa Leading expands device programming services to include security provisioning with the SentriX Deployment Platform…
Management to host conference call and webcast at 4:30 pm ET on that day Boca…
EDMONTON, Alberta, Feb. 21, 2023 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”…
MILPITAS, Calif.–(BUSINESS WIRE)–$CRSR–CORSAIR® (NASDAQ: CRSR), a world leader in enthusiast components for gamers, creators, and…
Poster Session Highlights the Strong Dose-Response Relationship and the Importance of Treating Beyond 30 Treatments…
–Second field trial confirms Camelina tolerance to over-the-top herbicide application –Greenhouse studies support proof-of-concept for…
BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN) today announced that a…
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET SOUTH SAN FRANCISCO, Calif.,…
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
— Infant Phase 2 Study Initiation Expected in the Second Quarter of 2023, with Initial…
FREMONT, CA, Feb. 21, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
Results presented at 30th Conference on Retroviruses and Opportunistic Infections (CROI) SOLANA BEACH, Calif. and…
WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
CAMBRIDGE, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
MONTRÉAL, Feb. 21, 2023 (GLOBE NEWSWIRE) — Esperas Pharma, Inc. (“Esperas”), a company based in…